<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
<title>Truvex Research</title><link>https://truvexresearch.com</link><description>Independent education on peptide research</description>
<item><title>TB-500 Is Not Thymosin Beta-4. Why the Difference Matters When Reading the Research.</title><link>https://truvexresearch.com/research/tb-500-is-not-thymosin-beta-4</link><guid>https://truvexresearch.com/research/tb-500-is-not-thymosin-beta-4</guid><pubDate>Fri, 30 Oct 2026 12:00:00 GMT</pubDate><description>Much of what is said about TB-500 comes from studies of a different, much larger molecule. A new orthopaedic review spells out the gap, and the product-quality questions that come with it.</description></item>
<item><title>Two New Reviews Count the Human Evidence for BPC-157. It Comes to 30 People.</title><link>https://truvexresearch.com/research/bpc-157-human-evidence-two-reviews</link><guid>https://truvexresearch.com/research/bpc-157-human-evidence-two-reviews</guid><pubDate>Fri, 30 Oct 2026 12:00:00 GMT</pubDate><description>A systematic review and an orthopaedic narrative review, both published this month, reach the same finding: decades of animal work, and almost no controlled human data.</description></item>
</channel></rss>
